ES8303394A1 - Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina. - Google Patents

Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina.

Info

Publication number
ES8303394A1
ES8303394A1 ES505801A ES505801A ES8303394A1 ES 8303394 A1 ES8303394 A1 ES 8303394A1 ES 505801 A ES505801 A ES 505801A ES 505801 A ES505801 A ES 505801A ES 8303394 A1 ES8303394 A1 ES 8303394A1
Authority
ES
Spain
Prior art keywords
benzofuran
medicine
processes
preparation
ethanolamine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES505801A
Other languages
English (en)
Other versions
ES505801A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES8303394A1 publication Critical patent/ES8303394A1/es
Publication of ES505801A0 publication Critical patent/ES505801A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

METODO DE FABRICACION DE UNA PELICULA ORIENTADA BLAXIALMENTE DE POLIMEROS DE METILESTIRENO. LA PELICULA COMPRENDE UN POLIMERO TERMOPLASTICO DE ALTO PESO MOLECULAR QUE CONSTA ESENCIALMENTE DE POLI(P-METILESTIRENO), CONTENIENDO PREFERENTEMENTE MENOS DEL 5 POR 100 DE UNIDADES DE META-METILESTIRENO Y ESTA SUSTANCIALMENTE EXENTO DE UNIDADES DE ORTOMETILESTIRENO, MENOS DEL 0,1 POR 100, TENIENDO EL POLIMERO UNA TEMPERATURA DE TRANSICION VITREA SUPERIOR A 100 GRADOS C. SE PUEDEN INCORPORAR CARGAS, COLORANTES, ABRILLANTADORES OPTICOS, ESTABILIZANTES, PIGMENTOS Y AGENTES DESLIZANTES. SE PREPARA POR METODOS CONVENCIONALES DE PRODUCCION DE PELICULAS SOLIDAS.
ES505801A 1980-09-26 1981-09-25 Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina. Granted ES505801A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8031228 1980-09-26

Publications (2)

Publication Number Publication Date
ES8303394A1 true ES8303394A1 (es) 1983-02-01
ES505801A0 ES505801A0 (es) 1983-02-01

Family

ID=10516329

Family Applications (1)

Application Number Title Priority Date Filing Date
ES505801A Granted ES505801A0 (es) 1980-09-26 1981-09-25 Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina.

Country Status (12)

Country Link
US (1) US4432993A (es)
EP (1) EP0051917B1 (es)
JP (1) JPS5785383A (es)
AU (1) AU546104B2 (es)
CA (1) CA1175851A (es)
DE (1) DE3173816D1 (es)
ES (1) ES505801A0 (es)
GR (1) GR75048B (es)
IE (1) IE52076B1 (es)
NZ (1) NZ198389A (es)
PT (1) PT73712B (es)
ZA (1) ZA816567B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8615995D0 (en) * 1986-07-01 1986-08-06 Glaxo Group Ltd Veterinary preparations
GB8707122D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
US5061727A (en) 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5245053A (en) * 1990-05-04 1993-09-14 American Cyanamid Company Substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles
US5106867A (en) * 1990-05-04 1992-04-21 American Cyanamid Company Method of increasing lean meat in edible animals
US5151439A (en) * 1990-05-04 1992-09-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
AT395849B (de) * 1991-04-04 1993-03-25 Noe Christian R Pharmakologisch aktive in position 3 substituierte alpha-aminomethyl-2benzofuranmethanole
BR9406823A (pt) * 1993-06-14 1996-03-26 Pfizer Aminas secundárias e agentes anti-diabéticos e antiobesidade
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5627200A (en) * 1994-09-26 1997-05-06 Pfizer Inc β3 -Adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
EP0801060A1 (en) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclic Beta-3 Adrenergenic Agonists
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
EP0827746B1 (en) 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
CO5011072A1 (es) * 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
AU2003225277A1 (en) * 2002-05-02 2003-11-17 Robert Harris Lipid removal from the body

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE663926A (es) * 1964-05-20
US3929836A (en) * 1965-05-11 1975-12-30 Hoffmann La Roche 2-(2-Lower alkylamino-1-hydroxy-ethyl)-substituted benzofurans
GB1472959A (en) * 1974-09-26 1977-05-11 Roche Products Ltd Benzofuran derivatives and a process for the manufacture thereof
GB1509300A (en) * 1975-12-05 1978-05-04 Ici Ltd Ethanolamine derivatives
DE2946058A1 (de) * 1979-11-15 1981-05-21 I.P.U. Ltd., Nassau Feuerschutzabschlussvorrichtung

Also Published As

Publication number Publication date
EP0051917A1 (en) 1982-05-19
PT73712A (en) 1981-10-01
EP0051917B1 (en) 1986-02-19
IE812231L (en) 1982-03-26
US4432993A (en) 1984-02-21
AU546104B2 (en) 1985-08-15
PT73712B (en) 1982-12-30
ZA816567B (en) 1982-09-29
CA1175851A (en) 1984-10-09
AU7560381A (en) 1982-04-01
ES505801A0 (es) 1983-02-01
NZ198389A (en) 1984-03-30
DE3173816D1 (en) 1986-03-27
GR75048B (es) 1984-07-12
IE52076B1 (en) 1987-06-10
JPS5785383A (en) 1982-05-28

Similar Documents

Publication Publication Date Title
ES8303394A1 (es) Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina.
ES8103734A1 (es) Procedimiento para preparar nuevos derivados de piperidina
LU90053I2 (fr) Topotecan et ses sels et dérivés pharmaceutiquement acceptables (Hycamtin)
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
ES8306142A1 (es) "procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil)-bencimidazolonas sustituidas".
ES8207124A1 (es) Un procedimiento para la preparacion de derivados de aminas secundarias.
ES8501410A1 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES473441A1 (es) Procedimiento para la preparacion de nuevos derivados de 5,-11-dihidro-6h-pirido (2,3-b)(1,4-benzodiazepin-6-ona).
ES8205791A1 (es) Procedimiento para la preparacion de derivados de imidazol del sistema de 1,4-benzodioxan-2-ilo
ATE81850T1 (de) 3-aminopropyloxyphenylabkoemmlinge, herstellung und arzneitmittel die sie enthalten.
ES2000907A6 (es) Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos
ES8500953A1 (es) Procedimiento para preparar derivados de tieno-tiazol
ES8105715A1 (es) Procedimiento de preparar derivados isoquinolinicos
ES8800952A1 (es) Un procedimiento para la preparacion de derivados de carbapenem.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ES8702379A1 (es) Un procedimiento para la produccion de 1h-tetrazol-5-carboxamidas-n-sustituidas.
ES455940A1 (es) Procedimiento para la preparacion de 2,9-dioxatriciclo (4,3,1,03,7) decanos.
ES479440A1 (es) Un procedimiento para preparar compuestos con propiedades broncodilatadoras.
ATE18211T1 (de) Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen.
ES477092A1 (es) Un procedimiento para la preparacion de nuevos derivados de hidantoina.
ATE25516T1 (de) Neue carbonsaeure-derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel.
ES8303401A1 (es) Un procedimiento para la preparacion de derivados del 4,9-dihidro-4,9-dioxo-1h-nafto (2,3-d)v-triazol.
ES8305304A1 (es) "procedimiento de preparacion de derivados de etanolamina".
ES2007784A6 (es) Procedimiento para la preparacion de derivados de 1-alquil-ergolinil-tiourea>
ES481603A1 (es) Un procedimiento para la preparacion de un derivado de la hidantoina.